Is there a need for a new generation of vaccines against pertussis?

Expert Opinion on Emerging Drugs
Jann Storsaeter, Joanne Wolter

Abstract

Current vaccines against pertussis have proved their safety and efficacy in large-scale clinical trials. Despite high vaccination coverage, pertussis is still prevalent and increasing, probably as a result of waning immunity. Addition of new antigens, such as adenylate cyclase, to current vaccines might improve some aspects of the immune response to vaccination, but are unlikely to significantly increase the duration of protection. Intranasal, oral and DNA pertussis vaccines are some way from clinical development, although one live attenuated, intranasal pertussis vaccine may soon enter Phase I trials. In the meantime, the potential of currently available safe and efficacious pertussis vaccines should be maximised. Rationalisation of pertussis boosters in childhood and introduction of widespread repeat booster vaccination in adolescents and adults would already lessen disease prevalence and morbidity among susceptible infants.

References

Jan 1, 1977·Annual Review of Medicine·C C Linnemann, J Nasenbeny
Jan 1, 1990·Folia primatologica; international journal of primatology·O E GustavssonR Serrander
Oct 1, 1989·The Journal of Pediatrics·P C AdamsonP A Pizzo
Apr 1, 1987·The Pediatric Infectious Disease Journal·V RomanusS O Bergquist
Jun 1, 1995·Acta Paediatrica Japonica; Overseas Edition·T AoyamaY Saito
Jan 1, 1993·Vaccine·M Granström, G Granström
Jan 1, 1996·Clinical and Diagnostic Laboratory Immunology·E GrimprelN Guiso
Nov 1, 1996·The Journal of Infectious Diseases·J D Cherry
Dec 31, 1997·The Pediatric Infectious Disease Journal·J G LieseB H Belohradsky
Feb 20, 1999·Infection and Immunity·A A WeissC M Mink
Dec 22, 1999·Biologicals : Journal of the International Association of Biological Standardization·Y Sato, H Sato
Feb 26, 2000·Infection and Immunity·C L Weingart, A A Weiss
Feb 29, 2000·Epidemiology and Infection·P G Van BuynderE Miller
May 12, 2001·Vaccine·C A Siegrist
Jul 11, 2001·Microbes and Infection·K H Mills
Sep 25, 2001·Vaccine·D C Oliver, R C Fernandez
Oct 6, 2001·Vaccine·G Del GiudiceR Rappuoli
Jun 29, 2002·BMJ : British Medical Journal·N S Crowcroft, Joseph Britto
Aug 20, 2002·Vaccine·Robert L Hunter
Dec 7, 2002·The Lancet Infectious Diseases·C H Wirsing von KönigN Guiso

❮ Previous
Next ❯

Citations

Nov 3, 2011·Expert Review of Vaccines·Jan T PoolmanScott A Halperin
Sep 8, 2015·Vaccines·Alberta Di PasqualeNathalie Garçon
Jul 22, 2011·Enfermedades infecciosas y microbiología clínica·Joan TorresCarme Trilla
Dec 8, 2007·Emergency Medicine Australasia : EMA·M Omar FaruqueKeith Bg Dear
Dec 25, 2009·Renal Failure·Mohammad Mahdi SaghebGolmehr Sajjady
Aug 5, 2016·Clinical and Experimental Vaccine Research·Sonsire Fernández CastilloJosé Luis Pérez Quiñoy
Apr 21, 2016·Polish Journal of Veterinary Sciences·D ZieniusA Šalomskas
May 12, 2017·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Mehdi MahdaviChristine Hartoonian
Sep 14, 2007·Journal of Peptide Science : an Official Publication of the European Peptide Society·Ali Azizi, Francisco Diaz-Mitoma

❮ Previous
Next ❯

Related Concepts